VEGFA and hepatocellular carcinoma: Fortunately, the landscape of HCC treatment has rapidly evolved in recent years, especially with the development of regimens based on tyrosine-kinase inhibitors (TKIs) or vascular endothelial growth factor (VEGF) inhibitors and, more recently, immunotherapy [5, 6, 7, 8, 9].